Comerica Securities,Inc. Biogen Inc. Transaction History

Comerica Securities,Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$252.44 - $306.72 $13,884 - $16,869	55 New	55 $15,000
Q3 2019 Oct 15, 2019	BUY	$217.44 - $243.88 $479,890 - $538,243	2,207 New	2,207 $664,000
Q2 2019 Aug 09, 2019	SELL	$219.29 - $241.72 $451,518 - $497,701	-2,059 Closed	0 $0
Q1 2019 May 07, 2019	BUY	$216.71 - $338.96 $446,205 - $697,918	2,059 New	2,059 $487,000

1,018

126M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Comerica Securities,Inc., based on Form 13F filings with the SEC.

Stay updated on Comerica Securities,Inc. with notifications on news.